Kolexia
Cordonnier-Jourdin Catherine Pharmacien
Cordonnier-Jourdin Catherine
Pharmacien
Hôpital Henri Mondor
Créteil, France
170 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Tumeurs hématologiques Mycoses Pneumonie à Pneumocystis Neutropénie Pneumopathie infectieuse Leucémie aigüe myéloïde Infections à cytomégalovirus Maladies transmissibles

Collaborateurs

Voir plus
Robin Christine
Robin Christine
Hôpital Henri Mondor, Créteil, France
Maury Sebastien
Maury Sebastien
Hôpital Henri Mondor, Créteil, France
Bretagne Stephane
Bretagne Stephane
Hôpital Saint-Louis, Paris, France
Pautas Cecile
Pautas Cecile
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2022
Janssen
1 collaboration(s)
Dernière en 2020
Ethypharm
1 collaboration(s)
Dernière en 2023
Pfizer
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
The Lancet. Infectious diseases   19 décembre 2023
Empirical Versus Preemptive Antifungal Therapy: Empirical Versus Pre-emptive (Diagnostic-driven) Antifungal Therapy of Patients Treated for Haematological Malignancies or Receiving an Allogeneic Stem Cell Transplant. A Therapeutic Open Label Phase III Strategy Study of the EORTC Infectious Diseases and Leukemia Groups
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   08 décembre 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   30 novembre 2023
Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Transplantation and cellular therapy   23 novembre 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   23 octobre 2023
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM): A Phase 3, Randomized, Double-blind, Active Comparator-controlled, Multicenter Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Recipients of Allogeneic Hematopoietic Stem Cell Transplant (PNEU-STEM)
Essai Clinique (Merck & Co.)   20 juillet 2023
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).
Leukemia   17 juillet 2023
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT.
Bone marrow transplantation   06 mai 2023
Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.
The Lancet. Haematology   31 mars 2023
Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.
The Lancet. Haematology   31 mars 2023